New trends in the strategy of research and development of new drug in the post-financial-crisis eraFENG Ren-tian, BAI Hua1801-1805
Competition between originator and generic drugmakers from olmesartan patentFU Jing, LIU Jun-zheng1806-1809,1819
Development and prospect on the marketed drug sampling and testing for quality evaluationZHU Jia-liang, YANG Xia, LI Zhe-yuan, ZHU Jiong1810-1815
Considerations about clinical research strategy of cardiac safety for QT internal prolongation induced by new non-antiarrhythmic drugs in ChinaGENG Ying, ZHAO Deng-heng, YANG Huan, YANG Zhi-min1816-1819
Predication and application of targeted antitumor agents based on precision medicineZHANG Hui-xian, HE Qi-yang1820-1824,1830
Assay of potency for Xuezhikang by inhibiting HMG-CoA reductaseWANG Jing, WANG Qing, SUN Ji-ye, SHA Chun-jie, DUAN Zhen-wen, LIU Wan-hui1825-1830
A brief overview of regulations and research methods of drug non-clinical dependence evaluationJIANG Wei-ning, DONG Yan-sheng, JIANG Tao, WANG Xiao-fei, WANG Quan-jun1831-1837
Normalization of registration testing information of imported monoclonal antibody-based biotherapeuticsCHEN Yu-qin, LIU Chun-yu, GUO Wei, WANG Lan, GAO Kai1838-1842,1855
Advances in the chemical substances illegally adulterated in traditional Chinese medicines and health foodsXU Shuo, JIN Peng-fei, XU Qiao-ling, L(U) Xiao-chuan, HE Xiao-rong1843-1850
Technologies of Raman spectroscopy and its applications in drug researchREN Xiao-dan, LUO Xiang, FENG Hui, ZHONG You-quan, YIN Xiao-ying1851-1855